
|Articles|September 6, 2013
VIDEO: Avoidable Costs in U.S. Healthcare
Doug Long, VP, Industry Relations, IMS Health, discusses the report: "Avoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly."
Advertisement
Doug Long, VP, Industry Relations, IMS Health, discusses the report: "Avoidable Costs in U.S. Healthcare: The $200 Billion Opportunity from Using Medicines More Responsibly."
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Retatrutide Delivers Weight Loss, A1C Improvements in Additional Trials
2
FDA Votes in Favor of Peptides After Lengthy Deliberation
3
Pharmacists Need More Pharmacotherapy Knowledge for Managing Down Syndrome
4
FDA Approves Furoscix ReadyFlow, First Autoinjector for IV Furosemide
5



























